Editorial

DOI: 10.4244/EIJ-E-25-00037

Angina and coronary microvascular dysfunction: unravelling the links

Colin Berry1, BSc, MBChB, PhD; Rebecca Hanna1, MBChB

In this issue of EuroIntervention, Nogami et al present insights into how chest pain phenotypes relate to coronary microvascular dysfunction (CMD) and outcomes in patients with angina and non-obstructive coronary arteries (ANOCA)1. Their retrospective study of over 1,200 patients who underwent coronary reactivity testing (CRT) is among the largest to examine the relationship between symptom type (rest, exertional, or both), CMD and cardiovascular events. Of these patients, 299 (23.7%) reported exertional chest pain only and 341 (27.0%) reported resting chest pain only; their median age was 52 [interquartile range 44, 62] years, and 418 (65.3%) were female.

The work addresses an important clinical need. ANOCA is prevalent, affecting up to 50% of patients undergoing invasive coronary angiography for chest pain, and CMD is increasingly recognised as a central pathophysiological mechanism. However, symptom interpretation remains challenging in clinical practice. The authors demonstrated that participants with exertional chest pain had significantly lower coronary flow reserve (CFR; 2.8 vs 3.0; p<0.01) and blunted coronary blood flow (CBF) response to intracoronary infusion of acetylcholine (ACh) compared to those with resting symptoms. These findings...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 17
Sep 1, 2025
Volume 21 Number 17
View full issue


Key metrics

Suggested by Cory

Original Research

10.4244/EIJ-D-25-00277 Sep 1, 2025
Chest pain patterns and coronary microvascular function in non-obstructive coronary artery disease
Nogami K et al

Editorial

10.4244/EIJ-E-22-00033 Oct 21, 2022
Some endotypes of microvascular dysfunction may be more worrisome than others
Maas A and Damman P
free

Editorial

10.4244/EIJ-E-24-00011 Jun 3, 2024
The assessment of ANOCA: coming of age?
De Bruyne B and Mahendiran T
free

Debate

10.4244/EIJ-E-24-00072 Mar 17, 2025
Routine diagnosis of ANOCA/INOCA: pros and cons
Montone R et al
free

10.4244/EIJV14I5A89 Aug 3, 2018
Microvascular disease, what little we know
Appelman Y
free
Trending articles
95.7

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
61.2

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
35.45

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved